77 related articles for article (PubMed ID: 11721369)
41. Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia.
Abboud R; Han SY; Duncavage EJ; Cashen AF; Shirai CL; Welch JS; DiPersio JF; Abboud CN
Haematologica; 2019 Apr; 104(4):e170-e173. PubMed ID: 30733274
[No Abstract] [Full Text] [Related]
42. Vaccine hope for acute promyelocytic leukaemia.
Ahmad K
Lancet Oncol; 2003 Dec; 4(12):712. PubMed ID: 14682344
[No Abstract] [Full Text] [Related]
43. The B-box 1 dimer of human promyelocytic leukemia protein.
Huang SY; Naik MT; Chang CF; Fang PJ; Wang YH; Shih HM; Huang TH
J Biomol NMR; 2014 Dec; 60(4):275-81. PubMed ID: 25355412
[No Abstract] [Full Text] [Related]
44. Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?
Ammatuna E; Huls G
Ann Hematol; 2019 Jul; 98(7):1793-1794. PubMed ID: 31025159
[No Abstract] [Full Text] [Related]
45. Detection of differentiation in acute promyelocytic leukemia.
Tallman MS; Kwaan HC; Weitzman SA
Blood; 1991 Oct; 78(7):1892-3. PubMed ID: 1912572
[No Abstract] [Full Text] [Related]
46. "Growth hormone and acute promyelocytic leukemia".
Azagury M; Dombret H; Castaigne S; Degos L
Med Pediatr Oncol; 1995 Jan; 24(1):69-70. PubMed ID: 7968800
[No Abstract] [Full Text] [Related]
47. Acute promyelocytic leukemia following solid organ transplantation.
Rashidi A; Conkling PR; Fisher SI
Ann Hematol; 2016 Jan; 95(1):169-171. PubMed ID: 26453075
[No Abstract] [Full Text] [Related]
48. Searching the central nervous system for relapsed acute promyelocytic leukemia.
Stein EM; Tallman MS
Leuk Lymphoma; 2013 Dec; 54(12):2584-5. PubMed ID: 23662989
[No Abstract] [Full Text] [Related]
49. [Morphocytochemical characteristics of blast cells in the diagnosis and prognosis of the course of acute promyelocytic leukemia].
Shakhbazian GP; Abakumov EM; Isaev VG
Gematol Transfuziol; 1989 Apr; 34(4):59-61. PubMed ID: 2744383
[No Abstract] [Full Text] [Related]
50. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
51. [Molecular basis of arsenic action in promyelocytic leukemia cells].
Wysocki R; Wiśniewska E
Postepy Biochem; 2002; 48(2):121-30. PubMed ID: 12362602
[No Abstract] [Full Text] [Related]
52. [Advances in the study of etiology and differentiation induction mechanism of acute promyelocytic leukemia].
Liu T; Mao M; Chen Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):666-8. PubMed ID: 11721369
[No Abstract] [Full Text] [Related]
53. Marked for death.
Petrie K; Zelent A
Nat Cell Biol; 2008 May; 10(5):507-9. PubMed ID: 18454129
[No Abstract] [Full Text] [Related]
54. A new PML-RARs fusion transcript hints at the important role of PML dysregulation in the pathogenesis of APL.
Opalinska J; Zhou L; Verma A
Leuk Lymphoma; 2007 Mar; 48(3):443-4. PubMed ID: 17454578
[No Abstract] [Full Text] [Related]
55. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
56. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
